Melanoma Melanoma
Advanced Melanoma Immunotherapy Landscape: Positioning Novel and Emerging Agents
This activity is supported by an educational grant from Merck & Co., Inc.
Melanoma Insights: Focus on High-Risk Early-Stage to Advanced Disease Management
This activity is supported by an educational grant from Merck & Co., Inc.
Cancer detection rates improved the second year of the pandemic, but deficits remained
Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.
DecisionDx test can help identify sentinel lymph node risk
The melanoma 31-gene expression profile test can help physicians to better estimate risk for sentinel lymph nodes, possibly reducing the need for biopsies, according to a study.
Study finds more deaths associated with nonmelanoma skin cancer than melanoma
A higher proportion of patients are dying from nonmelanoma skin cancer globally than melanoma, according to a press release from the European Academy of Dermatology and Venerology.
What is carcinoma?
The most common type of cancer in humans is carcinoma.